Form 8-K - Current report:
SEC Accession No. 0001104659-07-081536
Filing Date
2007-11-09
Accepted
2007-11-09 10:18:02
Documents
9
Period of Report
2007-11-06
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a07-28552_18k.htm 8-K 44210
2 EX-99.1 a07-28552_1ex99d1.htm EX-99.1 207818
3 EX-99.2 a07-28552_1ex99d2.htm EX-99.2 192161
4 EX-99.3 a07-28552_1ex99d3.htm EX-99.3 32774
5 EX-99.4 a07-28552_1ex99d4.htm EX-99.4 31182
6 EX-99.5 a07-28552_1ex99d5.htm EX-99.5 31114
7 EX-99.6 a07-28552_1ex99d6.htm EX-99.6 31281
8 EX-99.6 a07-28552_1ex99d7.htm EX-99.7 19273
9 GRAPHIC g285521lqi001.jpg GRAPHIC 1745
  Complete submission text file 0001104659-07-081536.txt   593796
Mailing Address
Business Address 100 ABBOTT PARK ROAD D-322 AP6D ABBOTT PARK IL 60064-3500 8479376100
ABBOTT LABORATORIES (Filer) CIK: 0000001800 (see all company filings)

EIN.: 360698440 | State of Incorp.: IL | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-02189 | Film No.: 071228725
SIC: 2834 Pharmaceutical Preparations